Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-17-011331
Filing Date
2017-03-13
Accepted
2017-03-13 09:25:56
Documents
1
Period of Report
2017-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6616
  Complete submission text file 0001127602-17-011331.txt   7922
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
PATUSKY CHRISTOPHER (Reporting) CIK: 0001231427 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 17684158